Invention Grant
- Patent Title: Cationic lipids
-
Application No.: US17900412Application Date: 2022-08-31
-
Publication No.: US11993570B2Publication Date: 2024-05-28
- Inventor: Satoru Matsumoto , Yoshimasa Omori , Masahiro Mineno , Yasutaka Hoashi
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: McCarter & English, LLP
- Agent David G. Conlin
- Priority: JP 17254667 2017.12.28
- Main IPC: C07C229/12
- IPC: C07C229/12 ; A61K9/16 ; C07C69/533 ; C12N15/113

Abstract:
The present invention provides a technique that enables introduction of active ingredients, in particular, nucleic acids, into cells with superior efficiency; and cationic lipids, etc., for use in the technique. The compound or a salt thereof according to the present invention is a compound represented by formula (I) or a salt thereof. In formula (I), n represents an integer of 2 to 5, R represents a linear C1-5 alkyl group, a linear C7-11 alkenyl group, or a linear C11 alkadienyl group, and wavy lines each independently represent a cis-bond or a trans-bond.
Public/Granted literature
- US20230257338A1 CATIONIC LIPIDS Public/Granted day:2023-08-17
Information query